An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R. Good, Carl H. June, Austin K. Rennels et al.|Cell|2021Cited by 398
Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, K. Christopher García, Mikko Siurala et al.|Nature|2022Cited by 115
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapyNils Wellhausen, Carl H. June, Sangya Agarwal et al.|Current Opinion in Immunology|2021Cited by 22
Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptorsAnusha Kalbasi, K. Christopher García, Mikko Siurala et al.|Nature|2022Cited by 2